Last checked at 28 Apr 2011 12:48
BEXIMCO PHARMACEUTICALS LTD.
28th April 2011
PRICE SENSITIVE INFORMATION
Beximco Pharmaceuticals Ltd. ("BPL" or "Company": AIM Symbol: BXP) today announces information for the shareholders of the Company that the Board of Directors at their meeting held on 28th April 2011 has decided the following:
1. | To recommend the approval of the Financial Statements for the year ended 31 December 2010 | : | The results are expected to be announced week commencing 9th May 2011 |
2. | Date & Time of 35th AGM of the company for the year 2010 | : | 2nd July, 2011 at 12.30 PM |
3. | Venue of AGM | : | Beximco Industrial Park, Sarabo, Kashimpur, Gazipur, Bangladesh |
4. | Proposed Dividend for the year ended 31 December 2010 | : | 20% Stock Dividend (i.e. 20 shares for every 100 shares held) |
5. | Record date | : | 11th May , 2011 |
6. | Net Asset Value as at 31 December 2010 | : | Taka 15,974,086,451 |
7. | Net Asset Value per Share as at 31 December, 2010 | : | Taka 78.53 |
8. | Earnings per share ( EPS) for the year ended 31 December 2010 | : | Taka 5.17 |
9. | Net Operating Cash Flow per share for the year ended 31 December 2010 | : | Taka 6.65 |
For further information please visit www.beximco-pharma.com or enquire to:
Beximco Pharma
Nazmul Hassan, MP
Managing Director
Tel: +880 2 861 9151, ext.2080
Md. Asad Ullah, FCS, Company Secretary
Tel: +880 2 8618220-1, Ext 1140
Libertas
Jakob Kinde / Thilo Hoffmann
Tel: +44 (0)20 7569 9650
Financial Dynamics
Jonathan Birt / Susan Quigley
Tel: +44 (0)20 7269 7169
Notes to Editors
About Beximco Pharmaceuticals Limited
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.
The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.